ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,167Medicare Part D Prescriptions Filled, Including Refills

Rank: 199 out of 780

$489K Total Retail Price of All Prescriptions

Rank: 304 out of 780

358 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 358 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

47% of this provider’s 358 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 9,662 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,215 756 S3 1 1
OMEPRAZOLE 588 476 2 3
FUROSEMIDE 453 378 3 7
METOPROLOL TARTRATE 432 326 4 19
LEVOTHYROXINE SODIUM 387 294 5 5
POTASSIUM CHLORIDE 377 297 6 11
LISINOPRIL 369 245 7 6
AMLODIPINE BESYLATE 334 276 8 4
MELOXICAM 263 208 9 16
METFORMIN HCL 252 213 10 8
SIMVASTATIN 247 190 11 2
PRAVASTATIN SODIUM 223 157 12 9
WARFARIN SODIUM 213 184 13 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 180 133 14 26
CEFUROXIME 171 120 15 147
ATENOLOL 168 116 16 21
NEXIUM 167 73 17 22
ISOSORBIDE MONONITRATE ER 141 136 18 60
CYCLOBENZAPRINE HCL 135 66 R 19 42
CARISOPRODOL 131 21 R 20 67
GLIMEPIRIDE 128 109 21 30
CITALOPRAM HBR 124 88 22 23
CLONIDINE HCL 119 105 23 28
ZOLPIDEM TARTRATE 115 101 24 17
METOPROLOL SUCCINATE 115 97 24 20
PROMETHAZINE HCL 114 59 R 26 66
GABAPENTIN 113 57 27 13
KLOR-CON 10 111 85 28 90
SERTRALINE HCL 98 61 29 27
CLOPIDOGREL 97 97 30 34
ATORVASTATIN CALCIUM 95 79 31 12
RANITIDINE HCL 94 48 32 39
ESCITALOPRAM OXALATE 94 68 32 61
FLUOXETINE HCL 93 57 34 65
AZITHROMYCIN 92 54 35 38
ALLOPURINOL 89 73 36 29
METOCLOPRAMIDE HCL 85 58 37 102
TRAMADOL HCL 84 63 38 15
DONEPEZIL HCL 83 83 39 31
NAPROXEN 81 57 40 100
CARVEDILOL 79 67 41 14
LANTUS 73 38 42 71
AMITRIPTYLINE HCL 73 36 R 42 48
PLAVIX 71 71 44 45
CELEBREX 67 65 45 89
LEVOFLOXACIN 66 51 46 76
DIGOXIN 65 53 47 56
ROPINIROLE HCL 64 40 48 87
NAMENDA 64 50 48 46
TRAZODONE HCL 63 58 50 35
MIRTAZAPINE 63 56 50 58
DIVALPROEX SODIUM 63 24 50 119
CEPHALEXIN 60 41 53 105
ADVAIR DISKUS 60 54 53 68
TAMSULOSIN HCL 58 49 55 36
QUETIAPINE FUMARATE 58 55 55 81
POLYETHYLENE GLYCOL 3350 54 52 57 79
SPIRONOLACTONE 54 39 57 53
HYDROCHLOROTHIAZIDE 50 34 59 10
CIPROFLOXACIN HCL 50 43 59 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.